Annexon Inc (ANNX) - News Archive

Showing 4 of 24 results.

Annexon, Inc. Secures Substantial Funding Through Successful Public Offering, Paving the Way for Revolutionary Complement Medicines.

Annexon, Inc. Announces Successful Pricing of Public Offering, Strengthening Its Position in the Biopharmaceutical IndustryBrisbane, Calif. - Annexon, Inc. (NASDAQ: ANNX), a leading clinical-stage biopharmaceutical comp...

Dec 20, 2023 • Major Pharmaceutical Preparations Industry Shares

Annexon's ANX1502 Phase I Trial: What Promising Results Mean for Disease Treatment and Prevention

Experimental drug discovery and development is a rigorous, scientific process, often involving years of intensive research, testing, and hefty investment. Annexon Inc., a clinical-stage biopharmaceutical company, is no...

Dec 20, 2023 • Major Pharmaceutical Preparations Industry Clinical Study

Annexon Inc Bolsters Team with Inducement Grants as Share Price Stands at $1.72

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)Brisbane, Calif. - Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company specializing in developing novel complem...

Oct 18, 2023 Shares

Annexon Fortifies Team with Inducement Grant under Nasdaq Listing Rule, Bolstering Transformative Research and Development Efforts.

Annexon Reports Grant of Inducement to New Employee Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., Sept. 18, 2023 - Annexon, Inc. (Nasdaq: ANNX), a leading clinical-stage biopharmaceutical company specializing in...

Sep 18, 2023 Shares